Not a good buy right now: there are no Intellectia entry signals (both AI Stock Picker and SwingMax are inactive), and there are no identifiable near-term catalysts from news/flows.
Sentiment setup is uninspiring: recent analyst actions skew toward caution (downgrade to Market Perform and a Neutral initiation), which typically limits upside momentum.
For an impatient buyer unwilling to wait for better timing, this lacks a clear edge today; the better decision is to stay on the sidelines (hold/avoid new entry).
Technical Analysis
No technical trend data was provided (no price history/indicators), so the current trend, support/resistance, and momentum cannot be verified from the dataset.
Intellectia Proprietary Trading Signals (used here as a technical/timing proxy):
Intellectia Proprietary Trading Signals
With no active timing signals and no chart data, there is no confirmed technical entry setup today.
Positive Catalysts
Hedge funds and insiders are Neutral with no significant recent trends (reduces risk of negative flow-driven pressure).
No negative news in the last week (no immediate headline overhang).
Neutral/Negative Catalysts
No news catalysts in the last week: absence of event-driven upside drivers for a near-term move.
No active Intellectia signals (AI Stock Picker/SwingMax): weak timing/edge for immediate entry.
Recent analyst stance is cautious (downgrade + Neutral initiation), which can cap near-term re-rating potential.
No congress trading data available (no supportive signal from influential/political trading flows).
Financial Performance
Financial snapshot unavailable (data error: "list index out of range"), so latest quarter performance and growth trends cannot be assessed, and the latest quarter season cannot be confirmed from the provided data.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend is slightly negative/cautious:
2025-12-17: Itau BBA downgraded to Market Perform from Outperform (PT: CLP 4,600).
2026-01-08: UBS initiated at Neutral (PT: CLP 4,350).
Wall Street pros/cons view (based on provided coverage only):
Pros: still covered with mid-level ratings (not a broad bearish stance).
Cons: no Buy/Outperform ratings in the provided set; downgrade and Neutral initiation suggest limited conviction for immediate upside.
Wall Street analysts forecast AKO.A stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AKO.A is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0
Wall Street analysts forecast AKO.A stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AKO.A is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
0
Current: 26.960
Low
0
Averages
0
High
0
0
Current: 26.960
Low
0
Averages
0
High
0
UBS
Neutral
initiated
$4,350
AI Analysis
2026-01-08
Reason
UBS
Price Target
$4,350
AI Analysis
2026-01-08
initiated
Neutral
Reason
UBS initiated coverage of Embotelladora Andina with a Neutral rating and CLP 4,350 price target.
Itau BBA
Outperform -> Market Perform
downgrade
$4,600
2025-12-17
Reason
Itau BBA
Price Target
$4,600
2025-12-17
downgrade
Outperform -> Market Perform
Reason
Itau BBA downgraded Embotelladora Andina to Market Perform from Outperform with a CLP 4,600 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AKO.A
